Knoll Capital Management, LLC Diversified Active

Location: Miami, FL

CIK: 0001325083 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 14, 2018

Total Value: $118M (100.0% shares, 0.0% debt)

Holdings (19)

Abeona Therapeutics Inc 32.1%
Value $37.76M Shares 2,359,767 Est. Cost $4.97 Unrealized
Biohaven Pharmactl Hldg Co L 25.2%
Value $29.63M Shares 749,815 Est. Cost $25.00 Unrealized
Corbus Pharmaceuticals HLDGS 16.8%
Value $19.77M Shares 3,913,874 Est. Cost $4.42 Unrealized
Electrocore Inc 5.6%
Value $6.551M Shares 396,825 Est. Cost $16.51 Unrealized
Ampio Pharmaceuticals Inc. 4.9%
Value $5.71M Shares 2,595,484 Est. Cost $6.03 Unrealized
KRYS Krystal Biotech Inc 3.8%
Value $4.461M Shares 300,000 Est. Cost $10.08 Unrealized +11.3%
ENTX Entera Bio Ltd 2.5%
Value $2.996M Shares 475,540 Est. Cost $6.29 Unrealized 0.0%
Galmed Pharmaceuticals Ltd 2.1%
Value $2.499M Shares 210,000 Est. Cost $11.90 Unrealized
Vascular Biogenics LTD 1.7%
Value $1.973M Shares 896,771 Est. Cost $4.71 Unrealized
AVXL Anavex Life Sciences Corp 1.6%
Value $1.897M Shares 724,205 Est. Cost $3.56 Unrealized -21.6%
ALDX Aldeyra Therapeutics Inc 0.8%
Value $987K Shares 124,096 Est. Cost $10.20 Unrealized -21.8%
Eiger Biopharmaceuticals Inc 0.8%
Value $918K Shares 75,238 Est. Cost $9.85 Unrealized
Soligenix Inc. 0.7%
Value $813K Shares 837,800 Est. Cost $2.11 Unrealized
VNRX Volition RX LTD 0.6%
Value $703K Shares 351,538 Est. Cost $3.75 Unrealized -40.4%
Evoke Pharma Inc 0.6%
Value $688K Shares 275,000 Est. Cost $2.99 Unrealized
NAGE Chromadex Corp 0.2%
Value $178K Shares 47,866 Est. Cost $3.80 Unrealized 0.0%
Lipocine Inc New 0.1%
Value $65,000 Shares 50,000 Est. Cost $1.30 Unrealized
Catasys Inc 0.1%
Value $61,000 Shares 9,081 Est. Cost $6.72 Unrealized
Advaxis Inc. 0.0%
Value $20,000 Shares 112,500 Est. Cost $3.96 Unrealized